The global cancer immunotherapy market size is likely to reach USD 127.2 billion by 2026, exhibiting a CAGR of 9.7% during the forecast period 2019 to 2026. The growing incidences of cancer and a need to treat them is the key driver of the global im...
Plasmid manufacturing services are provided for various applications such as preclinical research studies, clinical trials, and commercial manufacturing. Pure, high-quality plasmid DNA is critical for a successful transfection. Research-grade plasmid...
Overview Non-alcoholic steatohepatitis (NASH) is liver disease which is categorized under the spectrum of non-alcoholic fatty liver disease (NAFLD). NASH is an advanced form of NAFLD where the liver inflammation occurs owing to fat deposition in liv...
Scope and Methodology This report on the vial adaptors for reconstitution drug market analyzes the current and future prospects of the market globally. The report comprises an elaborate executive summary, including a market snapshot that provides ov...
Increase in demand to enhance the aesthetic beauty and growth in preference for minimally invasive procedures majorly drive the market. In addition, increase in pool of geriatric population and introduction of better facial injectable such as synthet...
The global monoclonal antibody therapeutics market size was worth $97.7 bn in 2017 and is expected to reach US$275.8 bn by 2026. Between the forecast years of 2019 and 2026, the overall market is expected to rise at a CAGR of 17.6%. Monoclonal antib...
The global psoriasis treatment market is estimate this market to rise at a CAGR of 7.4% between 2019 and 2026 and reach US$13.3 bn by 2026. This report on the Psoriasis Treatment market analyzes the current and future scenario of the global market. ...
Overview With increase in the incidence of alpha mannosidosis worldwide the market for treatment is expected to grow in coming years. Alpha Mannosidosis is a rare inherited condition that leads to problems in organs and tissues of the body. The...
The global hormonal contraceptive market size is expected to reach USD 27.7 billion by 2026 and is estimated to expand at a CAGR of around 4.3% over the forecast period 2019 to 2026. The major driving factors of the market growth are increase in foc...
The market for NSCLC therapeutics presented a global opportunity worth US$5.7 bn in 2015. Analysts project it to rise at a CAGR of 13.80% during the period from 2019 to 2026 and attain a value of US$17.8 bn by the end of the forecast period 2019 to 2...